Skip to main content

Commit To Purchase Verve Therapeutics At $10, Earn 22.4% Annualized Using Options

Investors eyeing a purchase of Verve Therapeutics Inc (VERV) shares, but tentative about paying the going market price of $13.11/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the August put at the $10 strike, which has a bid at the time of this writing of 90 cents..
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.